Search

everythinglearnresearchcommunity

for

Search:↓

Herbal nano-formulations show potential for effective skin delivery but need more research.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Mice with the ab gene have abnormal sebaceous gland development, affecting sebum production.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Nanocarriers can improve skin drug delivery but face challenges in clinical use.

The skin has multiple layers and cells, serves as a protective barrier, helps regulate temperature, enables sensation, affects appearance, and is involved in vitamin D synthesis.

Sinapic acid may protect skin cells from UV damage and reduce inflammation, making it a promising anti-aging cosmetic ingredient.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Serenoa repens and N-acetyl glucosamine/milk proteins complex may help with hair growth and prevent hair loss.

Early hair loss may be linked to metabolic syndrome.

The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.

Premature hair loss doesn't increase the risk of metabolic syndrome.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

Adult offspring of sperm donation generally feel positive about their conception and view the donor as their biological father.

Lipid-based nanocosmeceuticals improve skin therapy by enhancing ingredient delivery and effectiveness for anti-aging and skin disorders.

Genetic mutations cause various hair diseases, and whole genome sequencing may reveal more about these conditions.

Nanotechnology could improve treatment for scars and atopic dermatitis by targeting skin issues more effectively.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

The new delivery method for finasteride using nanoparticles may improve hair growth without skin issues.

Managing alopecia areata in children needs a personalized approach considering genetic, immune, and environmental factors.

The congress showed advancements in skin hydration, barrier function, and safe, effective new cosmetic formulations.

Early-onset male hair loss may be linked to higher cardiovascular risk.

Rodent models of PCOS show some similar and some different lipid changes compared to humans.

Androgenetic alopecia may be linked to metabolic syndrome.

Hair loss in adults is linked to heart disease risk factors like unhealthy blood fats, lack of exercise, and alcohol use. It's also slightly more common in people with metabolic syndrome. As people age, hair loss gets worse. In men, severe hair loss is tied to high blood pressure and a larger waist. In women, it's tied to higher body weight. People with hair loss should be checked for unhealthy blood fats and advised to avoid alcohol and inactivity.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

The case emphasizes the need for careful screening in children for insulin resistance and related conditions.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.